# Sinopharm to acquire 60% stake in China National Scientific Instruments and Materials Co.

Sinopharm Group Co. Ltd. agreed to acquire a 60% equity interest in China National Scientific Instruments and Materials Co. Ltd. from its controlling shareholder for RMB 5.11 billion, to strengthen its medical device business.

- Type: Acquisition
- Announced: 2018-07-11
- Where: China
- Value: $770.0M (5.11B CNY)
- Status: announced
- Products: scientific instruments, medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sinopharm Group Co. Ltd.](https://endata.com/companies/33043.md) (acquirer)
- [China National Scientific Instruments and Materials Co. Ltd.](https://endata.com/companies/33044.md) (target)
- [China National Pharmaceutical Group Co. Ltd.](https://endata.com/companies/33045.md) (partner)

## Sources

- [ir.sinopharmgroup.com.cn](http://ir.sinopharmgroup.com.cn/html/news_detail.php?id=449382), 2018-07-11: "Sinopharm Group Co. Ltd. is pleased to announce that, on 11 July 2018, the Company and China National Pharmaceutical Group Co., Ltd. entered into the Asset Purchase Agreement."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.